Immunoreactivity of the Recombinant Protein after Refolding of Rhoptry Protein 2 and Major Surface Protein 1 from Toxoplasma Gondii
LI Wen-shu,ZHONG Xiao-zhi,CHEN Jun,ZHANG Li-fang,MIN Tai-shan,HUANG Wei-da
DOI: https://doi.org/10.3969/j.issn.1002-2694.2007.06.014
2007-01-01
Abstract:The recombinant rhoptry protein 2 (ROP2) and major surface protein 1(P30) from Toxoplasma gondii produced by gene-engineering technique were analyzed for their immunoactivities in vitro, and would be refolded to obtain the native conformation as a preparation to detect its immunoactivity in vivo. In this way, the recombinant plasmid pET28b/ROP2-P30 was transformed to E.coli BL21-coden plus (DE3)-RIL strain, and was expressed under induction with IPTG. Cells were lysed by multiple rounds of sonication, and the expressed products were analyzed by using SDS-PAGE. The recombinant protein ROP2-P30 was then refolded by Sephadex G-25 in a urea gradient, and the immunoreactivity of the recombinant ROP2-P30 renatured was tested with immuno-precipitation and immuno-blotting assay. It was demonstrated that the recombinant ROP2-P30 was expressed in E.coli as a fusion protein and was formed as an inclusion body. After refolding, it could be recognized by Toxoplasma-specific IgG antibody in human sera ,as demonstrated in immuno-precipitation and immuno-blotting assay. It is evident that the recombinant protein ROP2-P30 refolded by Sephadex G25 in a urea gradient has displayed its immunoactivity in vivo.